SINOVAC BIOTECH LTD
Income Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $174.3M | $72.4M | $67.4M | $62.9M | $71.8M | $49.2M | $56.8M | $33.4M |
| Cost of Revenue | $20.2M | $22.4M | $18.4M | $15.5M | $20.5M | $19.1M | $21.1M | $16.7M |
| Gross Profit | $154.1M | $50.0M | $49.0M | $47.5M | $51.3M | $30.1M | $35.7M | $16.7M |
| Gross Margin | 88.4% | 69.1% | 72.7% | 75.4% | 71.4% | 61.2% | 62.8% | 49.9% |
| Operating Expenses | ||||||||
| Research & Development | $20.5M | $12.6M | $9.5M | $10.9M | $8.1M | $17.0M | $9.0M | $8.5M |
| SG&A Expense | $87.4M | $42.0M | $37.5M | $34.3M | $33.6M | $33.3M | $23.8M | $18.9M |
| Operating Income | $45.4M | $504.0K | $3.7M | $1.9M | $9.9M | $-21.2M | $3.4M | $-13.4M |
| Operating Margin | 26.0% | 0.7% | 5.5% | 3.0% | 13.9% | -43.0% | 5.9% | -40.0% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | $45.0M | $-394.0K | $2.8M | $2.3M | $9.4M | $-19.6M | $4.7M | $-13.3M |
| Income Tax Expense | $8.3M | $2.7M | $3.0M | $2.1M | $-2.2M | $-884.0K | $5.1M | $-703.9K |
| Net Income | $25.8M | $-596.0K | $-1.4M | $-1.5M | $7.4M | $-18.7M | $-844.7K | $-8.5M |
| Net Margin | 14.8% | -0.8% | -2.1% | -2.4% | 10.4% | -38.1% | -1.5% | -25.5% |
| EPS (Basic) | $0.45 | $-0.01 | $-0.03 | $-0.03 | $0.13 | $-0.27 | $-0.02 | $-0.16 |
| EPS (Diluted) | $0.45 | $-0.01 | $-0.03 | $-0.03 | $0.13 | $-0.27 | $-0.02 | $-0.16 |
| Shares Outstanding (Basic) | 57.0M | 56.9M | 56.3M | 55.7M | 55.3M | 54.9M | 54.6M | 53.1M |
| Shares Outstanding (Diluted) | 57.1M | 56.9M | 56.3M | 56.1M | 55.8M | 54.9M | 54.6M | 53.1M |
| Dividends Per Share | — | — | — | — | — | — | — | — |